Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

The South Korean office of the Danish pharmaceutical company Novo Nordisk recently requested the local authorities to permit ...

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

If found to be lacking adequate compliance systems, Moderna could ultimately be suspended or expelled from the Association of ...